Pfizer Inc. (NYSE:PFE) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7, UBS initiated coverage of ...

Vertex and Medtronic could see strong momentum this year, while Pfizer is still facing challenges. Regardless of what happens ...

Sanofi Chief Executive Paul Hudson said on Wednesday the company is likely to see some weakness in U.S. vaccine demand this ...

Seven S&P 500 high-yield 'safer' dividend stocks—like Ford, AT&T, and VICI—offer strong payouts supported by free cash flow ...

Pfizer is taking a more hands-on approach to AI in drug research, teaming up with startup Boltz to help its scientists make ...

The post Stocks Move Lower As Earnings Disappoint-Market Analysis: January 13th, 2026 appeared first on Stock Target Advisor.

Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the ...

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...

Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted ...

CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a strategic collaboration to empower scientists across the company with ...

AbbVie (ABBV) inks Trump deal to cut Medicaid drug prices, expand TrumpRx discounts, and invest $100B in U.S. R&D for tariff relief.

We are inundated with technological hype. Self-driving cars, human-like robots and AI chatbots are the subject of sometimes ...